Industry Growth Insights published a new data on “Equine Pharmaceuticals and Supplements Market”. The research report is titled “Equine Pharmaceuticals and Supplements Market research by Types (Pharmaceuticals, Supplements), By Applications (Thoroughbred Horse, Other Types of Horses), By Players/Companies Boehringer Ingelheim, Merck Animal Health, Zoetis, Bayer Animal Health, Elanco Animal Health, Dechra Veterinary Products, CEVA, Virbac, Norbrook Equine, Kyoritsu Seiyaku, Vetoquinol, Protexin Healthcare, Audevard, Ouro Fino Saude”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Equine Pharmaceuticals and Supplements Market Research Report
By Type
Pharmaceuticals, Supplements
By Application
Thoroughbred Horse, Other Types of Horses
By Companies
Boehringer Ingelheim, Merck Animal Health, Zoetis, Bayer Animal Health, Elanco Animal Health, Dechra Veterinary Products, CEVA, Virbac, Norbrook Equine, Kyoritsu Seiyaku, Vetoquinol, Protexin Healthcare, Audevard, Ouro Fino Saude
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Equine Pharmaceuticals and Supplements Market Report Segments:
The global Equine Pharmaceuticals and Supplements market is segmented on the basis of:
Types
Pharmaceuticals, Supplements
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Thoroughbred Horse, Other Types of Horses
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boehringer Ingelheim
- Merck Animal Health
- Zoetis
- Bayer Animal Health
- Elanco Animal Health
- Dechra Veterinary Products
- CEVA
- Virbac
- Norbrook Equine
- Kyoritsu Seiyaku
- Vetoquinol
- Protexin Healthcare
- Audevard
- Ouro Fino Saude
Highlights of The Equine Pharmaceuticals and Supplements Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pharmaceuticals
- Supplements
- By Application:
- Thoroughbred Horse
- Other Types of Horses
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Equine Pharmaceuticals and Supplements Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Equine Pharmaceuticals and Supplements is a company that manufactures and sells supplements for horses. The company offers products that are designed to improve the health of horses, including vitamins, minerals, herbs, and other supplements.
Some of the major players in the equine pharmaceuticals and supplements market are Boehringer Ingelheim, Merck Animal Health, Zoetis, Bayer Animal Health, Elanco Animal Health, Dechra Veterinary Products, CEVA, Virbac, Norbrook Equine, Kyoritsu Seiyaku, Vetoquinol, Protexin Healthcare, Audevard, Ouro Fino Saude.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Equine Pharmaceuticals and Supplements Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Equine Pharmaceuticals and Supplements Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Equine Pharmaceuticals and Supplements Market - Supply Chain
4.5. Global Equine Pharmaceuticals and Supplements Market Forecast
4.5.1. Equine Pharmaceuticals and Supplements Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Equine Pharmaceuticals and Supplements Market Size (000 Units) and Y-o-Y Growth
4.5.3. Equine Pharmaceuticals and Supplements Market Absolute $ Opportunity
5. Global Equine Pharmaceuticals and Supplements Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Equine Pharmaceuticals and Supplements Market Size and Volume Forecast by Type
5.3.1. Pharmaceuticals
5.3.2. Supplements
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Equine Pharmaceuticals and Supplements Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Equine Pharmaceuticals and Supplements Market Size and Volume Forecast by Application
6.3.1. Thoroughbred Horse
6.3.2. Other Types of Horses
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Equine Pharmaceuticals and Supplements Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Equine Pharmaceuticals and Supplements Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Equine Pharmaceuticals and Supplements Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Equine Pharmaceuticals and Supplements Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Equine Pharmaceuticals and Supplements Demand Share Forecast, 2019-2026
9. North America Equine Pharmaceuticals and Supplements Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Equine Pharmaceuticals and Supplements Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Equine Pharmaceuticals and Supplements Market Size and Volume Forecast by Application
9.4.1. Thoroughbred Horse
9.4.2. Other Types of Horses
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Equine Pharmaceuticals and Supplements Market Size and Volume Forecast by Type
9.7.1. Pharmaceuticals
9.7.2. Supplements
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Equine Pharmaceuticals and Supplements Demand Share Forecast, 2019-2026
10. Latin America Equine Pharmaceuticals and Supplements Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Equine Pharmaceuticals and Supplements Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Equine Pharmaceuticals and Supplements Market Size and Volume Forecast by Application
10.4.1. Thoroughbred Horse
10.4.2. Other Types of Horses
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Equine Pharmaceuticals and Supplements Market Size and Volume Forecast by Type
10.7.1. Pharmaceuticals
10.7.2. Supplements
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Equine Pharmaceuticals and Supplements Demand Share Forecast, 2019-2026
11. Europe Equine Pharmaceuticals and Supplements Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Equine Pharmaceuticals and Supplements Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Equine Pharmaceuticals and Supplements Market Size and Volume Forecast by Application
11.4.1. Thoroughbred Horse
11.4.2. Other Types of Horses
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Equine Pharmaceuticals and Supplements Market Size and Volume Forecast by Type
11.7.1. Pharmaceuticals
11.7.2. Suppements
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Equine Pharmaceuticals and Supplements Demand Share, 2019-2026
12. Asia Pacific Equine Pharmaceuticals and Supplements Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Equine Pharmaceuticals and Supplements Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Equine Pharmaceuticals and Supplements Market Size and Volume Forecast by Application
12.4.1. Thoroughbred Horse
12.4.2. Other Types of Horses
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Equine Pharmaceuticals and Supplements Market Size and Volume Forecast by Type
12.7.1. Pharmaceuticals
12.7.2. Supplements
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Equine Pharmaceuticals and Supplements Demand Share, 2019-2026
13. Middle East & Africa Equine Pharmaceuticals and Supplements Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Equine Pharmaceuticals and Supplements Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Equine Pharmaceuticals and Supplements Market Size and Volume Forecast by Application
13.4.1. Thoroughbred Horse
13.4.2. Other Types of Horses
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Equine Pharmaceuticals and Supplements Market Size and Volume Forecast by Type
13.7.1. Pharmaceuticals
13.7.2. Supplements
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Equine Pharmaceuticals and Supplements Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Equine Pharmaceuticals and Supplements Market: Market Share Analysis
14.2. Equine Pharmaceuticals and Supplements Distributors and Customers
14.3. Equine Pharmaceuticals and Supplements Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Boehringer Ingelheim
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Merck Animal Health
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Zoetis
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bayer Animal Health
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Elanco Animal Health
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Dechra Veterinary Products
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. CEVA
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Virbac
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Norbrook Equine
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Kyoritsu Seiyaku
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Vetoquinol
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Protexin Healthcare
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Audevard
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Ouro Fino Saude
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook